Search
Patexia Research
Case number 1:18-cv-00672

H. Lundbeck A/S et al v. Torrent Pharmaceuticals Limited et al > Documents

Date Field Doc. No.Description (Pages)
Nov 23, 2020 18 Order (3)
Docket Text: CONSENT JUDGMENT, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 11/23/20. Associated Cases: 1:18-cv-00149-LPS, 1:18-cv-00672-LPS (ntl)
Nov 23, 2020 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: D.I. 18 was removed from the docket per request of counsel. (ntl)
Feb 28, 2019 17 Notice of Change of Address (1)
Docket Text: NOTICE of Change of Address by Arthur G. Connolly, III (Connolly, Arthur)
Jan 16, 2019 N/A Oral Order (0)
Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 1/16/2019. Associated Cases: 1:18-cv-00088-LPS et al.(dlb)
Jan 10, 2019 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00088-LPS et al.(cak)
Jul 9, 2018 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:18-cv-00088-LPS. (ntl)
Jul 3, 2018 16 Letter to The Honorable Leonard P. Stark (1)
Jul 3, 2018 16 Proposed Order (22)
Docket Text: PROPOSED ORDER -- Scheduling Order -- by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Letter to The Honorable Leonard P. Stark)(Blumenfeld, Jack)
Jun 19, 2018 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (13 in 1:18-cv-00753-LPS, 13 in 1:18-cv-00777-LPS, 16 in 1:18-cv-00671-LPS, 14 in 1:18-cv-00672-LPS, 11 in 1:18-cv-00853-LPS) MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 6/19/18. Associated Cases: 1:18-cv-00671-LPS, 1:18-cv-00672-LPS, 1:18-cv-00753-LPS, 1:18-cv-00777-LPS, 1:18-cv-00853-LPS (ntl)
Jun 19, 2018 N/A Scheduling Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Case Management Conference held on 6/19/2018. (Court Reporter: Hawkins Reporting) Associated Cases: 1:18-cv-00088-LPS et al. (ntl)
Jun 19, 2018 15 Answer to Counterclaim (12)
Docket Text: ANSWER to [9] Answer to Complaint,, Counterclaim, by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc..(Blumenfeld, Jack)
Jun 18, 2018 14 Motion for Leave to Appear Pro Hac Vice (11)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Einar Stole, and Brianne Bharkhda - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack)
Jun 12, 2018 13 Proposed Order (23)
Docket Text: PROPOSED ORDER Scheduling Order by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Cover Letter)(Blumenfeld, Jack)
Jun 12, 2018 13 Cover Letter (1)
Jun 8, 2018 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (21 in 1:18-cv-00177-LPS, 21 in 1:18-cv-00089-LPS, 23 in 1:18-cv-00114-LPS, 17 in 1:18-cv-00147-LPS, 41 in 1:18-cv-00175-LPS, 15 in 1:18-cv-00092-LPS, 12 in 1:18-cv-00672-LPS, 13 in 1:18-cv-00671-LPS, 28 in 1:18-cv-00088-LPS, 23 in 1:18-cv-00113-LPS, 11 in 1:18-cv-00753-LPS, 9 in 1:18-cv-00777-LPS, 23 in 1:18-cv-00148-LPS, 20 in 1:18-cv-00150-LPS, 20 in 1:18-cv-00176-LPS, 19 in 1:18-cv-00091-LPS, 17 in 1:18-cv-00090-LPS, 16 in 1:18-cv-00149-LPS) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 filed by Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc., H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals U.S.A., Inc. Signed by Judge Leonard P. Stark on 6/7/18. Associated Cases: 1:18-cv-00088-LPS et al. (ntl)
Jun 6, 2018 12 Stipulation to EXTEND Time (14)
Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to June 12, 2018 - filed by H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc.. (Blumenfeld, Jack)
May 29, 2018 9 Answer to Complaint (20)
Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. by Torrent Pharma Inc., Torrent Pharmaceuticals Limited.(Connolly, Arthur)
May 29, 2018 10 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Torrent Pharmaceuticals Ltd. for Torrent Pharma Inc. filed by Torrent Pharma Inc.. (Connolly, Arthur)
May 29, 2018 11 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Torrent Private Ltd. for Torrent Pharmaceuticals Limited filed by Torrent Pharmaceuticals Limited. (Connolly, Arthur)
May 11, 2018 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Takeda Pharmaceutical Company Ltd., H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc.. Torrent Pharmaceuticals Limited served on 5/9/2018, answer due 5/30/2018. (Blumenfeld, Jack)
May 11, 2018 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Takeda Pharmaceutical Company Ltd., H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals America, Inc.. Torrent Pharma Inc. served on 5/9/2018, answer due 5/30/2018. (Blumenfeld, Jack)
May 9, 2018 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:18-cv-00671-LPS, 1:18-cv-00672-LPS (rjb)
May 3, 2018 N/A Summons Issued (0)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Torrent Pharma Inc. on 5/3/2018; Torrent Pharmaceuticals Limited on 5/3/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg)
May 3, 2018 6 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceuticals U.S.A., Inc. for Takeda Pharmaceuticals America, Inc.; Corporate Parent Takeda Pharmaceutical Company Ltd., Other Affiliate Takeda Pharma A/S, Other Affiliate Takeda Europe Holdings B.V. for Takeda Pharmaceuticals International AG; Other Affiliate Takeda Pharmaceutical Company Ltd., Other Affiliate Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc.; Corporate Parent Takeda Europe Holdings B.V. for Takeda Pharmaceutical Company Ltd. filed by Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals U.S.A., Inc. (ceg)
May 3, 2018 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (ceg)
May 3, 2018 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,861,630 B1. (ceg)
May 3, 2018 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/23/2017. Date of Expiration of Patent: 6/15/2027.Thirty Month Stay Deadline: 3/30/2021. (ceg)
May 3, 2018 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg)
May 3, 2018 1 Civil Cover Sheet (2)
May 3, 2018 1 Exhibit A (47)
May 3, 2018 1 Complaint* (1)
Menu